Zhao M,Cai H,Li X,et al.Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese[J].J Transl Med,2012,10:57.
[2]
Tang M,Zeng Y,Poisson A,et al.Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population[J].Genes Immun,2010,11(4):334-342.
[3]
Nong LG,Luo B,Zhang L,et al.Interleukin-18gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population[J].DNA Cell Biol,2009,28(10):507-513.
[4]
Xiao M,Zhang L,Zhu X,et al.Genetic polymorphisms of MDM2and TP53genes are associated with risk of nasopharyngeal carcinoma in a Chinese population[J].BMC Cancer,2010,10:147.
[5]
Dickson RI,Flores AD.Nasopharyngeal carcinoma:an evaluation of 134patients treated between 1971-1980[J].Laryngoscope,1985,95(3):276-283.
[6]
Tse KP,Su WH,Chang KP,et al,Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3[J].Am J Hum Genet,2009,85(2):194-203.
[7]
Makni H,Daoud J,Ben Salah H,et al.HLA association with nasopharyngeal carcinoma in southern Tunisia[J].Mol Biol Rep,2010,37(5):2 533-2 539.
[8]
Ghandri N,Gabbouj S,Farhat K,et al.Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome[J].Hum Immunol,2011,72(2):150-158.
[9]
Cho EY,Hildesheim A,Chen CJ,et al.Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1and hOGG1[J].Cancer Epidemiol Biomarkers Prev,2003,12(10):1 100-1 104.
[10]
Laantri N,Jalbout M,Khyatti M,et al.XRCC1and hOGG1genes and risk of nasopharyngeal carcinoma in North African countries[J].Mol Carcinog,2011,50(9):732-737.
[11]
Huang GL,Guo HQ,Yu CY,et al.XRCC1polymorphisms and risk of nasopharyngeal carcinoma:a metaanalysis[J].Asian Pac J Cancer Prev,2011,12(9):2 329-2 333.
Hadhri-Guiga B,Toumi N,Khabir A,et al.Proline homozygosity in codon 72of TP53is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia[J].Cancer Genet Cytogenet,2007,178(2):89-93.
[15]
Zhou G,Zhai Y,Cui Y,et al.MDM2 promoter SNP309is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population[J].Clin Cancer Res,2007,13(9):2 627-2 633.
[16]
Sousa H,Pando M,Breda E,et al.Role of the MDM2SNP309polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma[J].Mol Carcinog,2011,50(2):73-79.
[17]
Cheng D,Kong H,Li Y.Prognostic value of interleukin-8and MMP-9in nasopharyngeal carcinoma[J].Eur Arch Otorhinolaryngol,2013,271(3):503-509.
[18]
Wang T,Hu K,Ren J,et al.Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population[J].Mol Biol Rep,2010,37(1):59-65.
[19]
Guo X,O'Brien SJ,Zeng Y,et al.GSTM1and GSTT1gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese[J].Cancer Epidemiol Biomarkers Prev,2008,17(7):1 760-1 763.
[20]
Bei JX,Li Y,Jia WH,et al.A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci[J].Nat Genet,2010,42(7):599-603.
Ng CC,Yew PY,Puah SM,et al.A genome-wide association study identifies ITGA9conferring risk of nasopharyngeal carcinoma[J].J Hum Genet,2009,54(7):392-397.
[23]
Kongruttanachok N,Sukdikul S,Setavarin S,et al.Cytochrome P450 2E1polymorphism and nasopharyngeal carcinoma development in Thailand:a correlative study[J].BMC Cancer,2001,1:4.
[24]
Jia WH,Pan QH,Qin HD,et al.A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese[J].Carcinogenesis,2009,30(12):2 031-2 036.
[25]
Guo X,Zeng Y,Deng H,et al.Genetic Polymorphisms of CYP2E1,GSTP1,NQO1and MPO and the Risk of Nasopharyngeal Carcinoma in a Han Chinese Population of Southern China[J].BMC Res Notes,2010,3:212.
Li Q,Wang JM,Peng Y,et al.Association of DNA Base-excision Repair XRCC1,OGG1and APE1 Gene Polymorphisms with Nasopharyngeal Carcinoma Susceptibility in a Chinese Population[J].Asian Pac J Cancer Prev,2013,14(9):5 145-5 151.
[29]
Tsai MH,Chen WC,Tsai FJ.Correlation of p21gene codon 31polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma[J].J Clin Lab Anal,2002,16(3):146-150.
[30]
Sousa H,Breda E,Santos AM,et al.Genetic risk markers for nasopharyngeal carcinoma in Portugal:tumor necrosis factor alpha-308G>A polymorphism[J].DNA Cell Biol,2011,30(2):99-103.
[31]
Gao LB,Liang WB,Xue H,et al.Genetic polymorphism of interleukin-16and risk of nasopharyngeal carcinoma[J].Clin Chim Acta,2009,409(1-2):132-135.
[32]
Qin X,Peng Q,Lao X,et al.The association of interleukin-16gene polymorphisms with IL-16serum levels and risk of nasopharyngeal carcinoma in a Chinese population[J].Tumour Biol,2013,35(3):1 917-1 924.
[33]
Farhat K,Hassen E,Bouzgarrou N,et al.Functional IL-18promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients[J].Cytokine,2008,43(2):132-137.
